An attempt was made to study the prevalence of ectoparasite damage on live cattle, sheep and goats in and around Kombolcha town and on raw goat skin to assess their skin defect on processed wet-blue (pickled) skins at Kombolcha tannery, south wollo zone, NorthEastern Ethiopia. A total of 240 cattle, 175 sheep, 66 goats, were used to study the prevalence of ectoprasites on live animals as well as 344 fresh goat pelts and pickled (wet-blue) goat skins were used to assess skin defects. The result obtained from live cattle demonstrated a high prevalence of Amblyomma (28.33%) followed by Sarcoptes scabiei (23.75%), Boophilus (11.25%) Demodex (9.58%), Psoroptes (0.4 %), respevtively. The prevalence of ectoprasite infestation of live sheep revealed Mellophagus ovinus (sheep ked) (32.57%), Bovicola ovis (22.28%), Amblyomma spp (12.57%), Sarcoptes scabiei (14.28 %), Ctenocephaliedes spp (8.57%), Demodex (6.85%), Linognathus africanus (6.28%) and Boophilus spp (4%). The result from goats demonstrates a high prevalence of Sarcoptes scabiei (30.3%) followed by Linognathus stenopsis (9.09%), Amblyomma (4.54%), Ctenocephalides spp (3.03%), Bovicola caprea (1.51%) and Demodex (1.51%) in that order. Result obtained from fresh goats pelts revealed an over all high prevalence of Sacoptes scabie (53.29%) followed by Linognathus stenopsis (9.88%), Bovicola caprae (2.08%) and Demodex (2.08%). Examination of pickled (wet-blue) skins from follow-up skins show a high prevalence of scratch (74.25%) followed by "Ekek" (68.56%), scar (67.06%), processing defect (28.44%). "Ekek" (Typical scatter type cockle) was found to show a significant (P<0.5) association with Sarcoptes scabiei, Linoganthus stenopsis, scratch and diseases scars, indicating the likely multifactor causes and one major skin problems in the study area.
Mastitis is the most common disease of dairy cattle worldwide causing economic losses due to reduced yield and poor quality of milk. It is of particular concern in Ethiopia, where effective prevention and control practices are lacking. The objective of the present prospective longitudinal study was to estimate the incidence rate clinical mastitis (CM), identify the risk factors, isolate the bacterial agents and determine the risk of recurrence. For this purpose, a total of 217 lactating cows were followed-up every two weeks from calving to drying off or the end of the study period. Of these, 79 (36.41%) developed CM, of which 23% had recurrent infection in the same or a different quarter. The overall incidence rate of CM was found to be 83.72 (95% CI: 63.2 to 98.2) cases per 100 cow-years at risk. In the multivariable Cox regression model, the risk of CM was found to be significantly (p < 0.05) higher in multiparous cows (HR = 1.96), in cows with a history of mastitis (HR = 2.04), in cows that had severely keratinized teat end condition (HR = 7.72) and in cows kept in poorly cleaned barns (HR = 1.89). The pathogenic bacteria isolated from mastitis positive cows were Staphylococcus aureus (28.1%), E. coli (21.1%), Bacillus spp. (14%), Streptococcus spp. (14%), Coagulase Negative Staphylococcus (12.3%), other coagulase positive Staphylococcus spp. (5.3%), Enterobacter spp. (3.5%), Klebsiella spp. (1.8%), Corynebacterium spp. (1.8%), Actinobacillus spp, (1.8%) and Proteus spp. (1.8%). The high incidence rate of CM in the present study shows that the disease spreads rapidly and can be responsible for a significant economic loss to milk producers in the study area. Therefore, raising awareness among dairy farmers, early detection and treatment of cases, post milking teat disinfection, improvement of the hygienic status of cows and barns, use of dry cow therapy, and culling of chronic cases are recommended as viable measures to prevent and control clinical mastitis in the study area.
Mastitis is the most common disease of dairy cattle worldwide, causing economic losses due to reduced yield and poor quality of milk. It is of particular concern in Ethiopia, where effective prevention and control practices are lacking. The objective of the present prospective longitudinal study was to estimate the incidence rate of clinical mastitis (CM), identify the risk factors, isolate the bacterial agents, and determine the risk of recurrence. For this purpose, a total of 217 lactating cows were followed up every two weeks from calving to drying off or the end of the study period. Of these, 79 (36.41%) developed CM, of which 23% had recurrent infections in the same or a different quarter. The overall incidence rate of CM was 83.72 (95% CI: 63.2–98.2) cases per 100 cow-years at risk. In the multivariable Cox regression model, the risk of CM was found to be significantly higher in multiparous cows (HR = 1.96; p = 0.03), in cows with a history of mastitis (HR = 2.04; p = 0.030), in cows that had severely keratinized teat end condition (HR = 7.72; p < 0.001) and in cows kept in poorly cleaned barns (HR = 1.89; p = 0.007). The pathogenic bacteria isolated from mastitis-positive cows were Staphylococcus aureus (28.1%), E. coli (21.1%), Bacillus spp. (14%), Streptococcus spp. (14%), coagulase-negative staphylococci (12.3%), non aureus staphylococci (5.3%), Enterobacter spp. (3.5%), Klebsiella spp. (1.8%), Corynebacterium spp. (1.8%), and Proteus spp. (1.8%). The high incidence rate of CM in the present study shows that the disease spreads rapidly and can be responsible for a significant economic loss to milk producers in the study area. Therefore, raising awareness among dairy farmers, early detection and treatment of cases, post-milking teat disinfection, improvement of the hygienic status of cows and barns, use of dry cow therapy, and culling of chronic cases are recommended as viable measures to prevent and control clinical mastitis in the study area.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.